Galanthamine hydrobromide
It is an anticholinesterase drug with a weak anticholinesterase effect and can cross the blood-brain barrier, so it has a relatively strong effect on the central nervous system. It restores the impeded neuromuscular conduction and improves the paralysis of various peripheral neuromuscular disorders.
classification：
Product Center
Key words:
Product Description
It is an anticholinesterase drug with a weak anticholinesterase effect and can cross the blood-brain barrier, so it has a relatively strong effect on the central nervous system. It restores the impeded neuromuscular conduction and improves the paralysis of various peripheral neuromuscular disorders. It has a wide therapeutic range, is less toxic and is more easily tolerated by patients. It is mainly used clinically to treat the sequelae of poliomyelitis (polio), muscle atrophy and myasthenia gravis. It can also be used for children with cerebral palsy, traumatic sensorimotor disorders, polyneuritis and spinal radiculitis, etc.
CAS No.: 1953-04-4
EINECS No.: 217-780-5
Molecular formula: C17H21NO3.HBr
Molecular weight: 368.27
Properties: white crystalline powder; odorless, bitter taste.
Solubility: soluble in water, slightly soluble in ethanol, insoluble in chloroform and ether.
Melting point: 258℃~264℃
Boiling point: 439.336°C at 760 mmHg
Flash point: 219.503°C
Vapor pressure: 0mmHg at 25°C
Detection method: High performance liquid chromatography detector (HPLC)
Specification: (HPLC)≥99%
Storage: airtight, cool, dry, protected from light and high temperature, shelf life is two years.
Next
Next
Related products
Message
Contacts
© COPYRIGHT 2023 Wuhan Shiji Pharmaceutical Co.,Ltd. ALL RIGHTS RESERVED | Business license | SEO | Powered by www.300.cn